| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.51M | 8.26M | 7.00M | 4.46M | 131.00K | 142.00K |
| Gross Profit | 2.90M | 3.32M | 2.73M | 634.00K | 131.00K | 140.00K |
| EBITDA | -3.82M | -3.60M | -5.10M | -7.92M | -10.44M | -6.07M |
| Net Income | -3.56M | -4.00M | -6.38M | -8.31M | -10.52M | -6.17M |
Balance Sheet | ||||||
| Total Assets | 11.65M | 10.06M | 8.99M | 9.73M | 12.56M | 3.57M |
| Cash, Cash Equivalents and Short-Term Investments | 4.49M | 4.88M | 2.19M | 2.10M | 10.67M | 1.69M |
| Total Debt | 946.00K | 276.00K | 694.00K | 998.00K | 611.00K | 708.00K |
| Total Liabilities | 4.36M | 3.15M | 4.26M | 5.19M | 1.70M | 1.49M |
| Stockholders Equity | 7.30M | 6.91M | 4.74M | 4.54M | 10.86M | 2.08M |
Cash Flow | ||||||
| Free Cash Flow | -3.53M | -3.10M | -6.11M | -7.32M | -7.32M | -5.72M |
| Operating Cash Flow | -3.50M | -3.09M | -6.11M | -7.29M | -7.30M | -5.68M |
| Investing Cash Flow | -211.94K | 53.00K | -7.00K | -993.00K | 161.00K | -211.00K |
| Financing Cash Flow | 5.80M | 5.59M | 6.13M | -67.00K | 16.29M | 6.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | $3.73M | -0.69 | -60.58% | ― | -22.01% | 93.14% | |
48 Neutral | $5.70M | -0.13 | ― | ― | -17.95% | -124.63% | |
47 Neutral | $4.64M | -0.41 | -41.11% | ― | ― | ― | |
41 Neutral | $10.43M | -0.06 | -269.14% | ― | -73.83% | 98.11% | |
40 Underperform | $2.57M | >-0.01 | ― | ― | -19.53% | 92.37% |
On December 29, 2025, MySize issued a CEO letter to shareholders outlining how the company has evolved into a unified platform operating four revenue-generating businesses in AI-driven sizing, commerce enablement, resale infrastructure, and data intelligence for the global fashion industry. The company reported that, based on current run-rate and contracted customers, it expects to close 2025 with approximately $10 million in revenue and around $4 million in year-end cash, and indicated that its existing resources fund its current operating plan, shifting management’s focus toward execution, integration, and disciplined scaling. The letter also highlighted an expected revenue trajectory toward about $15 million in 2026, driven largely by expansion with existing customers and cross-selling across its integrated businesses, with management emphasizing progress toward operating breakeven, growing operating leverage, and a disciplined approach to capital allocation and potential strategic opportunities after several challenging early years as a pre-revenue public company.
The most recent analyst rating on (MYSZ) stock is a Hold with a $0.99 price target. To see the full list of analyst forecasts on My Size stock, see the MYSZ Stock Forecast page.
On December 15, 2025, My Size, Inc. granted restricted stock awards to its executive officers under its 2017 Equity Incentive Plan, allocating varying amounts of performance-based and time-based shares to the CEO, chief growth officer, chief product and operating officer, and chief financial officer, with a portion of the chief growth officer’s time-based award vesting immediately. The remaining time-based awards are scheduled to vest in three equal annual installments on January 1, 2026, 2027 and 2028, while the performance-based awards will vest only if specified profit and business targets are met, aligning executive compensation more closely with long-term company performance and retention objectives.
The most recent analyst rating on (MYSZ) stock is a Hold with a $0.99 price target. To see the full list of analyst forecasts on My Size stock, see the MYSZ Stock Forecast page.